Anticonvulsant screening of luteolin in four mouse seizure models

Neuroscience Letters

Volumn 550, Issue , 2013, Pages 195-199

  Shaikh, Mohd Farooq ^a,b   Tan, Kah Ni ^a   Borges, Karin ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

6Hz; Flavonoid; Inflammation; Pentylenetetrazole; Pilocarpine; TLR4

Indexed keywords

GREEN FLUORESCENT PROTEIN; LUTEOLIN; PORPHOBILINOGEN DEAMINASE; TATA BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; SEIZURE; SEIZURE THRESHOLD; SIGNAL TRANSDUCTION; UPREGULATION;

6HZ; FLAVONOID; INFLAMMATION; PENTYLENETETRAZOLE; PILOCARPINE; TLR4;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROSHOCK; LUTEOLIN; MALE; MICE; PENTYLENETETRAZOLE; PILOCARPINE; SEIZURES;

EID: 84881371911     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.065     Document Type: Article

References (26)

1. Jager A.K., Saaby L. Flavonoids and the CNS. Molecules 2011, 16:1471-1485.
2. Shaikh M.F., Sancheti J., Sathaye S. Phytochemical and pharmacological investigations of Eclipta alba (Linn) hassak leaves for antiepileptic activity. Int. J. Pharm. Pharm. Sci. 2012, 4:319-323.
3. Joshi D., Naidu P.S., Singh A., Kulkarni S.K. Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J. Med. Food 2005, 8:392-396.
4. Zhou F., Qu L., Lv K., Chen H., Liu J., Liu X., Li Y., Sun X. Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway. J. Neurosci. Res. 2011, 89:1859-1868.
5. Coleta M., Campos M.G., Cotrim M.D., Lima T.C., Cunha A.P. Assessment of luteolin (3',4',5,7-tetrahydroxyflavone) neuropharmacological activity. Behav. Brain Res. 2008, 189:75-82.
6. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
7. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
8. Turrin N.P., Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 2004, 16:321-334.
9. Maroso M., Balosso S., Ravizza T., Liu J., Bianchi M.E., Vezzani A. Interleukin-1 type 1 receptor/toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J. Intern. Med. 2011, 270:319-326.
10. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
11. Rodgers K.M., Hutchinson M.R., Northcutt A., Maier S.F., Watkins L.R., Barth D.S. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 2009, 132:2478-2486.
12. Kao T.K., Ou Y.C., Lin S.Y., Pan H.C., Song P.J., Raung S.L., Lai C.Y., Liao S.L., Lu H.C., Chen C.J. Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 2011, 22:612-624.
13. Dirscherl K., Karlstetter M., Ebert S., Kraus D., Hlawatsch J., Walczak Y., Moehle C., Fuchshofer R., Langmann T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J. Neuroinflamm. 2010, 7:3.
14. Lee J.K., Kim S.Y., Kim Y.S., Lee W.H., Hwang D.H., Lee J.Y. Suppression of the TRIF-dependent signaling pathway of toll-like receptors by luteolin. Biochem. Pharmacol. 2009, 77:1391-1400.
15. Kim J.S., Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005, 115:375-387.
16. Kharatishvili I., Shan Z.Y., She D.T., Foong S., Kurniawan N.D., Reutens D.C. MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy. Brain Struct. Funct. 2013.
17. Schlupper D., Giesa S., Gebhardt R. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity. Planta Med. 2006, 72:596-603.
18. Chen X., Liu L., Sun Z., Liu Y., Xu J., Liu S., Huang B., Ma L., Yu Z., Bi K. Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration. Biomed. Chromatogr. 2010, 24:826-832.
19. Samala R., Willis S., Borges K. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 2008, 81:119-127.
20. Giardina W.J., Gasior M. Acute seizure tests in epilepsy research: electroshock and chemical induced convulsions in the mouse. Curr. Protoc. Pharmacol. 2009, 1. 5.22.1-5.22.37.
21. Willis S., Stoll J., Sweetman L., Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 2010, 40:565-572.
22. Smeland O.B., Hadera M.G., McDonald T.S., Sonnewald U., Borges K. Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice. J. Cereb. Blood Flow Metab. 2013, (Epub).
23. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (RESEARCH0034).
24. Benson M., Thomas N.K., She D.T., Woodruff T.M., Singh Y., Hodson M., Borges K. Nanomolar levels of a cyclic anti-inflammatory peptide protects against electrically induced seizures in mice. Annual American Epilepsy Society Meeting 2012.
25. Kim do Y., Vallejo J., Rho J.M. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J. Neurochem. 2010, 114:130-141.
26. Hartman A.L., Lyle M., Rogawski M.A., Gasior M. Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia 2008, 49:334-339.